Izumi Kurata
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies 6
- Systemic Lupus Erythematosus Research 5
- IgG4-Related and Inflammatory Diseases 2
-
- Toxin Mechanisms and Immunotoxins 2
-
- Cell Adhesion Molecules Research 4
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Cytokine Signaling Pathways and Interactions 3
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Co-authors
- Isao MatsumotoTakayuki SumidaHiroto TsuboiYuya KondoAtsumu OsadaAkihito IshigamiShinya HagiwaraN. Umeda
- Cited by
- MicrobiologyRheumatologyImmunology
- Partner nations
- Japan
In The Last Decade
Izumi Kurata
19 papers receiving 267 citations
Peers
Comparison fields: 5 of 51
- Microbiology 6
- Rheumatology 107
- Immunology 119
- Immunology and Allergy 21
- Hematology 23
Countries citing papers authored by Izumi Kurata
This map shows the geographic impact of Izumi Kurata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izumi Kurata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izumi Kurata more than expected).
Fields of papers citing papers by Izumi Kurata
This network shows the impact of papers produced by Izumi Kurata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izumi Kurata. The network helps show where Izumi Kurata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Izumi Kurata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 21 | |
| 2 | 2021 | 5 | |
| 3 | 2021 | 9 | |
| 4 | 2021 | 10 | |
| 5 | 2020 | 5 | |
| 6 | 2020 | 8 | |
| 7 | 2020 | 15 | |
| 8 | 2020 | 46 | |
| 9 | 2019 | 26 | |
| 10 | 2019 | 38 | |
| 11 | 2019 | 6 | |
| 12 | 2018 | 17 | |
| 13 | 2018 | 21 | |
| 14 | 2018 | 8 | |
| 15 | 2017 | 5 | |
| 16 | 2016 | 8 | |
| 17 | 2015 | 2 | |
| 18 | 2015 | 6 | |
| 19 | 2014 | 12 |
About Izumi Kurata
Izumi Kurata is a scholar working on Microbiology, Rheumatology, Immunology and Allergy, Immunology and Cancer Research, having authored 19 papers that have together received 268 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (6 papers), Systemic Lupus Erythematosus Research (5 papers), Cell Adhesion Molecules Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Toxin Mechanisms and Immunotoxins (2 papers), IgG4-Related and Inflammatory Diseases (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Microbiology (6 citations), Rheumatology (107 citations), Immunology (119 citations), Immunology and Allergy (21 citations) and Hematology (23 citations). Izumi Kurata has collaborated with scholars based in Japan. Frequent co-authors include Isao Matsumoto, Takayuki Sumida, Hiroto Tsuboi, Yuya Kondo, Atsumu Osada, Akihito Ishigami, Shinya Hagiwara, N. Umeda, Hiroyuki Takahashi and Fumika Honda. Their work appears in journals such as Modern Rheumatology, Clinical & Experimental Immunology, Lupus, Annals of the Rheumatic Diseases and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.